Braveheart Bio Inc. IPO Research Information

Braveheart Bio Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Braveheart Bio Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Braveheart Bio Inc.	BRVE - NASDAQ	$15.00-$17.00	$18.00	$30.20	21.25 million	8/6/2026
Underwriter(s): Goldman Sachs, Jefferies, TD Cowen, Stifel, Cantor
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2026-07-15 Terms Added 2026-07-30

Braveheart Bio Inc. Quote & Chart - Click for current quote - BRVE

About Braveheart Bio Inc. (adapted from Braveheart Bio Inc. prospectus):
They are a clinical?stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (“HCM”) and other serious cardiovascular diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "BRVE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.